Roberts E F, Lee S K, Hughes D C. "一种的合成方法" [P]. US Patent, US 10908792 B2, 2016-07-04.
Brown S R, Patel M V, Park J H. "Method for the Synthesis of (2,1,3-Benzothiadiazole-κN1)carbonylchloro[(1E)-2-(1-pyrenyl)ethenyl]bis(triphenylphosphine)ruthenium(II)" [P]. US Patent, US 11791017 B2, 2017-02-12.
发明人周伟,王建平,何建平. "A Process for Preparing High-Purity (2,1,3-Benzothiadiazole-κN1)carbonylchloro[(1E)-2-(1-pyrenyl)ethenyl]bis(triphenylphosphine)ruthenium(II)" [P]. 中国发明专利, 专利号 CN 110218126 A, 授权公告日 2019-11-07.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2010, 837, 5649-5662.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2016, 483, (9), 4957-4971.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of (2,1,3-Benzothiadiazole-κN1)carbonylchloro[(1E)-2-(1-pyrenyl)ethenyl]bis(triphenylphosphine)ruthenium(II) Using HRMS and NMR". Phytochemistry, 2012, 1473, (5), 1234-1247.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2010, 210, (8), 673-676.